Qualitative beta-2-adrenoceptor signaling in the regulation of human airway epithelia mucin and cytokine production
Open Access
- 1 May 2026
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Abstract
Background: Numerous in vivo studies have demonstrated beta-2-adrenoceptor (β 2 AR) -agonism as permissive in the development of allergic lung inflammation, and have implicated the arrestin-dependent signaling arm of the β 2 AR in mediating this effect. However, the specific cell type(s) mediating β 2 AR regulation of allergic lung inflammation remain unestablished. Methods: To explore the potential contribution of airway epithelia in this phenomenon, we compared the ability of ractopamine (RP), recently identified as a Gs-biased beta-agonist, to that of the unbiased/balanced beta-agonist albuterol (ALB), on IL-13-stimulated mucin and cytokine production in human airway epithelia cultures in air–liquid interface (HAE). Results: ALB, which activates both the β 2 AR-arrestin and -Gs signaling pathways significantly augmented IL-13-induced mucin production in HAE. RP, which preferentially signals via Gs/PKA, did not. Although IL-13 stimulated production of numerous cytokines, including IL-1α, IL-1RA, MDC, TGF-α, and GROα, ALB-mediated augmentation of these cytokines was highly variable and not statistically significant. Similarly, RP did not augment the induction of cytokines stimulated by IL-13. Moreover, in contrast to previous studies that reported a requirement of concomitant β 2 AR agonism for IL-13 to stimulate cytokine production, such a requirement was observed only in minority of the (12) cultures examined. Conclusions: These data implicate arrestin-dependent β 2 AR signaling augmenting airway epithelial mucin production as a contributor to the previously-demonstrated pro-inflammatory effects of β 2 AR agonism in vivo. Moreover, they suggest that beta-agonist effects on the cytokine profile in the allergen-inflamed lung may be influenced by specific asthmatic endotypes and involve cooperativity among multiple cell types.Keywords
Funding Information
- National Institutes of Health (NIH NIAID R01AI16129)
This publication has 50 references indexed in Scilit:
- The β2-adrenergic receptor agonist terbutaline upregulates T helper-17 cells in a protein kinase A-dependent mannerHuman Immunology, 2023
- T-cell responses in asthma exacerbationsAnnals of Allergy, Asthma & Immunology, 2022
- Biased agonism at β-adrenergic receptorsCellular Signalling, 2021
- The Cytokines of AsthmaImmunity, 2019
- Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthmaCurrent Opinion in Pharmacology, 2014
- The beta2-adrenergic receptor on T and B lymphocytes: Do we understand it yet?Brain, Behavior, and Immunity, 2012
- Beta-2 adrenergic agonists: focus on safety and benefits versus risksCurrent Opinion in Pharmacology, 2010
- Mobilization of γδ T lymphocytes in response to psychological stress, exercise, and β-agonist infusionBrain, Behavior, and Immunity, 2009
- Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysJournal of Allergy and Clinical Immunology, 2004
- Modulation of T Cell Proliferation by Stimulation of the β-Adrenergic Receptor: Lack of Correlation between Inhibition of T Cell Proliferation and cAMP AccumulationCellular Immunology, 1993